+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biomedical Testing & Analysis Services Market by Technology, End Users, Test Type, Sample Type - Global Forecast 2025-2030- Product Image
Biomedical Testing & Analysis Services Market by Technology, End Users, Test Type, Sample Type - Global Forecast 2025-2030- Product Image
Sale

Biomedical Testing & Analysis Services Market by Technology, End Users, Test Type, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011411
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biomedical Testing & Analysis Services Market grew from USD 3.17 billion in 2023 to USD 3.38 billion in 2024. It is expected to continue growing at a CAGR of 7.94%, reaching USD 5.42 billion by 2030.

The biomedical testing and analysis services market play a critical role in the healthcare ecosystem by providing essential diagnostic and analytical services that aid in medical research, drug development, and patient care. The scope encompasses various forms of laboratory services, including but not limited to genetic testing, blood analysis, microbiological testing, and imaging services. These services are necessary for the accurate detection of diseases, understanding patient genotypes for personalized medicine, and ensuring the safety and efficacy of pharmaceuticals. The application spans multiple sectors such as clinical diagnostics, pharmaceutical research, public health, and biotechnological advancements, with end-users including hospitals, clinical laboratories, research institutions, and pharmaceutical companies. Growth in this market is propelled by factors such as technological advancements in testing methodologies, increasing prevalence of chronic diseases, a growing demand for personalized medicine, and rising health awareness among the population. Emerging opportunities lie in the integration of artificial intelligence and machine learning for data analysis, enhancing the accuracy and speed of diagnostics, and the development of non-invasive testing techniques. Expanding services in emerging markets and collaborations with tech firms can also open new avenues. However, the market faces challenges such as high costs of advanced diagnostic equipment, regulatory hurdles, and issues related to data privacy and security. Innovating in areas like portable diagnostic devices, improving data interoperability, and developing cost-effective testing methods can drive business growth. The market is competitive with an increasing focus on precision medicine and digital health solutions. Companies should focus on developing strategic partnerships and investing in R&D to stay abreast of technological advancements. Leveraging big data for predictive analysis and exploring the potential of telemedicine in remote diagnostics are promising strategies to navigate the evolving landscape of biomedical testing and analysis services.

Understanding Market Dynamics in the Biomedical Testing & Analysis Services Market

The Biomedical Testing & Analysis Services Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing demand for early disease detection and personalized medical treatment driving the biomedical testing market
    • Advancements in technology and automation enhancing the accuracy and efficiency of biomedical testing services
    • Rising prevalence of chronic diseases and aging population contributing to the growth of biomedical testing services
    • Growing adoption of genomics and proteomics studies in drug development and disease treatment boosting the market
  • Market Restraints
    • Difficulties in ensuring stringent regulatory requirements and compliance standards for biomedical testing and analysis services
    • Intense competition from in-house testing capabilities and advanced automated systems in biomedical research facilities
  • Market Opportunities
    • Collaborative partnerships between biotech firms and diagnostic labs accelerating innovation
    • Increased focus on non-invasive testing methods promoting more frequent and accessible healthcare screenings
    • Regulatory landscape and funding opportunities supporting advances in biomedical testing and analysis
  • Market Challenges
    • Data privacy and security concerns associated with biomedical testing & analysis services
    • Lack of skilled professionals including lab technicians, bioinformatics experts, and clinical researcher

Exploring Porter’s Five Forces for the Biomedical Testing & Analysis Services Market

Porter’s Five Forces framework further strengthens the insights of the Biomedical Testing & Analysis Services Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Biomedical Testing & Analysis Services Market

External macro-environmental factors deeply influence the performance of the Biomedical Testing & Analysis Services Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Biomedical Testing & Analysis Services Market

The Biomedical Testing & Analysis Services Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Biomedical Testing & Analysis Services Market

The Biomedical Testing & Analysis Services Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Biomedical Testing & Analysis Services Market

The Biomedical Testing & Analysis Services Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomedical Testing & Analysis Services Market, highlighting leading vendors and their innovative profiles. These include BioIVT, BioReliance Corporation, Charles River Laboratories International, Inc., Covance Inc., Envigo, Eurofins Scientific, Frontage Laboratories, Inc., ICON Central Laboratories, ICON plc, Inotiv, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Medpace Holdings, Inc., Parexel International Corporation, Pharmaceutical Product Development, LLC, PPD, Inc., PRA Health Sciences, Inc., SGS SA, Syneos Health, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Biomedical Testing & Analysis Services Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Technology
    • Cell-Based Tests
      • Cell Viability Assays
      • High Content Screening
      • Live Cell Imaging
    • Clinical Chemistry
    • Hematology
    • Immunoassays
      • ELISA
      • Radioimmunoassay
      • Western Blot
    • Mass Spectrometry
      • Metabolomics
      • Proteomics
    • Microbiological Testing
    • Molecular Diagnostics
      • DNA Sequencing
      • Isothermal Nucleic Acid Amplification
      • Microarray
      • PCR
  • End Users
    • Biotechnology & Pharmaceutical Companies
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Research Institutions & Academic Centers
  • Test Type
    • Diagnostic
    • Preliminary Testing
    • Prognostic
    • Screening
    • Therapeutic Monitoring
  • Sample Type
    • Blood
    • Cerebrospinal Fluid
    • Saliva
    • Stool
    • Tissue Biopsy
    • Urine
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for early disease detection and personalized medical treatment driving the biomedical testing market
5.1.1.2. Advancements in technology and automation enhancing the accuracy and efficiency of biomedical testing services
5.1.1.3. Rising prevalence of chronic diseases and aging population contributing to the growth of biomedical testing services
5.1.1.4. Growing adoption of genomics and proteomics studies in drug development and disease treatment boosting the market
5.1.2. Restraints
5.1.2.1. Difficulties in ensuring stringent regulatory requirements and compliance standards for biomedical testing and analysis services
5.1.2.2. Intense competition from in-house testing capabilities and advanced automated systems in biomedical research facilities
5.1.3. Opportunities
5.1.3.1. Collaborative partnerships between biotech firms and diagnostic labs accelerating innovation
5.1.3.2. Increased focus on non-invasive testing methods promoting more frequent and accessible healthcare screenings
5.1.3.3. Regulatory landscape and funding opportunities supporting advances in biomedical testing and analysis
5.1.4. Challenges
5.1.4.1. Data privacy and security concerns associated with biomedical testing & analysis services
5.1.4.2. Lack of skilled professionals including lab technicians, bioinformatics experts, and clinical researcher
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Biomedical Testing & Analysis Services Market, by Technology
6.1. Introduction
6.2. Cell-Based Tests
6.2.1. Cell Viability Assays
6.2.2. High Content Screening
6.2.3. Live Cell Imaging
6.3. Clinical Chemistry
6.4. Hematology
6.5. Immunoassays
6.5.1. ELISA
6.5.2. Radioimmunoassay
6.5.3. Western Blot
6.6. Mass Spectrometry
6.6.1. Metabolomics
6.6.2. Proteomics
6.7. Microbiological Testing
6.8. Molecular Diagnostics
6.8.1. DNA Sequencing
6.8.2. Isothermal Nucleic Acid Amplification
6.8.3. Microarray
6.8.4. PCR
7. Biomedical Testing & Analysis Services Market, by End Users
7.1. Introduction
7.2. Biotechnology & Pharmaceutical Companies
7.3. Diagnostic Laboratories
7.4. Hospitals & Clinics
7.5. Research Institutions & Academic Centers
8. Biomedical Testing & Analysis Services Market, by Test Type
8.1. Introduction
8.2. Diagnostic
8.3. Preliminary Testing
8.4. Prognostic
8.5. Screening
8.6. Therapeutic Monitoring
9. Biomedical Testing & Analysis Services Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Cerebrospinal Fluid
9.4. Saliva
9.5. Stool
9.6. Tissue Biopsy
9.7. Urine
10. Americas Biomedical Testing & Analysis Services Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Biomedical Testing & Analysis Services Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Biomedical Testing & Analysis Services Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET RESEARCH PROCESS
FIGURE 2. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET DYNAMICS
TABLE 7. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL VIABILITY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY LIVE CELL IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS & ACADEMIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PRELIMINARY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STOOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 116. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 118. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 119. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 120. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 121. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 122. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 123. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 124. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 126. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 127. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 128. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 129. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 130. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 134. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 140. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 142. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 143. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 144. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 145. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 146. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 147. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 148. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 156. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 158. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 166. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 174. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 178. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 179. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 182. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 183. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 185. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 188. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 190. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 191. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 192. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 193. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 194. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 195. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 196. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 198. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 199. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 200. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 201. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 202. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 203. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 213. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 215. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 216. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 217. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 218. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 219. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 220. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 221. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 223. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 224. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 225. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 226. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 227. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 228. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 229. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 231. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 232. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 233. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 234. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 235. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 236. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 237. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 239. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 240. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 241. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 242. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 243. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 244. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 245. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 247. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 248. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 249. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 250. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 251. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 252. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 253. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 255. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 261. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 263. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 264. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 265. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 266. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 267. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 268. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 285. NORWAY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. NORWAY BIOMEDICAL TESTING & ANALYSIS SERVICES MARK

Companies Mentioned

The leading players in the Biomedical Testing & Analysis Services market, which are profiled in this report, include:
  • BioIVT
  • BioReliance Corporation
  • Charles River Laboratories International, Inc.
  • Covance Inc.
  • Envigo
  • Eurofins Scientific
  • Frontage Laboratories, Inc.
  • ICON Central Laboratories
  • ICON plc
  • Inotiv, Inc.
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • Pharmaceutical Product Development, LLC
  • PPD, Inc.
  • PRA Health Sciences, Inc.
  • SGS SA
  • Syneos Health
  • WuXi AppTec

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.42 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Contaminant Testing & Analysis Services Market by Type, End-User, Technology, Contaminant - Global Forecast 2025-2030 - Product Image

Contaminant Testing & Analysis Services Market by Type, End-User, Technology, Contaminant - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Automated Test Equipment Market by Component, Testing Type, Application, End User - Global Forecast 2025-2030 - Product Image

Automated Test Equipment Market by Component, Testing Type, Application, End User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Healthcare Testing, Inspection, and Certification (TIC) - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Healthcare Testing, Inspection, and Certification (TIC) - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Global Non-destructive Testing (NDT) Services Market by Type (Inspection, Training, Others), Method (Radiographic, Ultrasonic, Others), Application (Flaw Detection, Others), End-use Industry (Oil & Gas, Manufacturing, Others) & Geography - Forecast to 2030 - Product Image

Global Non-destructive Testing (NDT) Services Market by Type (Inspection, Training, Others), Method (Radiographic, Ultrasonic, Others), Application (Flaw Detection, Others), End-use Industry (Oil & Gas, Manufacturing, Others) & Geography - Forecast to 2030

  • Report
  • 315 Pages
  • Global
From
Global Non-Destructive Testing and Inspection Market by Test Method, Offering, Vertical, Regional Outlook - Forecast up to 2030 - Product Image

Global Non-Destructive Testing and Inspection Market by Test Method, Offering, Vertical, Regional Outlook - Forecast up to 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.